Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Comparison with Other Treatments : In a separate Phase 1 trial for T2D participants, CT-868 demonstrated lower plasma glucose and lower insulin levels compared to liraglutide (an unbiased GLP-1 receptor agonist) and placebo, suggesting a potential unique mechanism of action beneficial for glucose regulation, without being dependent on weight loss
La RussaDGiordanoFMarroneAParafatiMJandaEPellegrinoD
10.1105/tpc.12.10.1939 Plant Cell 58 MartretB
10.1016/j.metabol.2020.154324 33 YuY.HaoG.ZhangQ.HuaW.WangM.ZhouW.et al (2015)
Youll typically hear back within 24-48 hours
Proper digestion will make one feel full longer, resulting in weight loss
US$ 25.66
US$ 26.02
US$ 25.00
